5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Flow Cytometry Market is segmented by Product Type (Instrument, Kit and Reagent, Software, and Other Product Types), Technology, Application, End-User, and Geography.
Fastest Growing Market:
The global flow cytometry market is expected to grow with a CAGR of 8.3% during the forecast period. The key factors propelling the market include the rise in the use of flow cytometry in stem cell research, the emergence and commercial application of new technologies in the field of flow cytometry, and rise in the applications of flow cytometry in clinical research.
There is a significance of flow cytometry in clinical research that is fueling the demand for flow cytometry techniques in R&D departments of the healthcare sector. The increasing incidences of HIV and cancer statistics show a significant unmet opportunity in cancer and AIDS diagnostics. There is a large void in diagnostics accessibility, particularly in the developing regions. Consequently, the increasing incidences of HIV AIDS and cancer can be considered a significant growth opportunity for the flow cytometry market.
Flow cytometry is a laser or an impedance-based technology, which is used in cell counting, detecting biomarker, cell sorting, and protein engineering, by suspending the cell in a stream of fluid and then passing them through a detection apparatus. It is the ideal tool to identify, characterize, and isolate stem and progenitor cells, for research and potential clinical use.
|Kit and Reagent|
|Other Product Types|
|Cell-based Flow Cytometry|
|Bead-based Flow Cytometry|
|Stem Cell Therapy|
|By End User|
|Hospitals and Clinics|
|Academia and Research Institutes|
|Pharmaceutical and Biotechnology Companies|
|Other End Users|
Report scope can be customized per your requirements. Click here.
The major factors responsible for the large market share include the extensive use of flow cytometry for effective diagnosis and early detection of numerous diseases that have helped the market to gain immense shares. There has been a growing market penetration in stem cell research, adoption of recombinant DNA technology for antibody production, and the evolution of tandem flow cytometry technologies that are expected to offer growth opportunities for the players operating in the flow cytometry market during the forecast period.
Though flow cytometry has also found many applications in several stages of drug discovery, its routine widespread use for high throughput drug screening has been limited. This is unlike analogous technology, automated high content imaging (HCI), which, in terms of drug screening, is an established technology that is common in screening laboratories.
To understand key trends, Download Sample Report
North America holds a major share of the flow cytometry market and is projected to continue over the next few years. In addition, there has also been a rise in the expansion of novel products that are anticipated to offer new growth opportunities in the coming years.
In the North America region, the united states hold the major share, this is mainly due to the factors such as the increase in the number of common cancers in the United States are breast cancer, lung cancer, prostate cancer, colon and rectum cancer, bladder cancer, and skin cancer.
The role of flow cytometry as an aid in determining prognosis in patients with cancer has become increasingly important with the advent of assays for the detection of minimal residual disease and assessment of multiple drug resistance.
Companies, like Sysmex, in the United States are investing in R&D, hence the market is expanding at a faster pace.
To understand geography trends, Download Sample Report.
The flow cytometry market is considered highly consolidated due to the presence of very few players in the market. These players are holding a huge share of the market and are likely to remain in a similar competitive environment for the next few years. The rising importance of product development and the rise in R&D activities are projected to encourage the growth of the flow cytometry market. In the coming years few other players are expected to enter into the market.
1.1 Study Deliverables
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Adoption of Flow Cytometry in Stem Cell Research
4.2.2 Increasing Applications of Flow Cytometry in Clinical Research
4.3 Market Restraints
4.3.1 Lack of Awareness about the Potential Benefits of Flow Cytometry Techniques
4.3.2 High Cost of the Equipment
4.4 Industry Attractiveness - Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 Product Type
5.1.2 Kit and Reagent
5.1.4 Other Product Types
5.2.1 Cell-based Flow Cytometry
5.2.2 Bead-based Flow Cytometry
5.3.2 Drug Discovery
5.3.3 Disease Diagnosis
5.3.4 Stem Cell Therapy
5.3.5 Organ Transplantation
5.3.7 Other Applications
5.4 By End User
5.4.1 Hospitals and Clinics
5.4.2 Academia and Research Institutes
5.4.3 Pharmaceutical and Biotechnology Companies
5.4.4 Other End Users
5.5.1 North America
126.96.36.199 United States
188.8.131.52 United Kingdom
184.108.40.206 Rest of Europe
220.127.116.11 South Korea
18.104.22.168 Rest of Asia-Pacific
5.5.4 Middle East & Africa
22.214.171.124 South Africa
126.96.36.199 Rest of Middle East & Africa
5.5.5 South America
188.8.131.52 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Danaher (Beckman Coulter)
6.1.3 Merck KGaA
6.1.4 Bio-Rad Laboratories
6.1.5 Luminex Corporation
6.1.6 Life Technologies
6.1.7 Miltenyi Biotech
6.1.8 Sysmex Partec GmbH
6.1.9 Agilent Technologies
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies, and Recent Developments